Division of Medical Oncology, Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
Department of Biomedical Informatics, Ohio State University, Columbus, Ohio, USA.
Cancer Med. 2024 Sep;13(17):e70095. doi: 10.1002/cam4.70095.
Tumor genomic testing (TGT) is standard-of-care for most patients with advanced/metastatic cancer. Despite established guidelines, patient education prior to TGT is frequently omitted. The purpose of this study was to evaluate the impact of a concise 4 min video for patient education prior to TGT.
Based on a quality improvement cycle, an animated video was created to be applicable to any cancer type, incorporating culturally diverse images, available in English and Spanish. Patients undergoing standard-of-care TGT were enrolled at a tertiary academic institution and completed survey instruments prior to video viewing (T1) and immediately post-viewing (T2). Instruments included: (1) 10-question objective genomic knowledge; (2) 10-question video message-specific knowledge; (3) 11-question Trust in Provider; (4) attitudes regarding TGT.
A total of 150 participants were enrolled. For the primary objective, there was a significant increase in video message-specific knowledge (median 10 point increase; p < 0.0001) with no significant change in genomic knowledge/understanding (p = 0.89) or trust in physician/provider (p = 0.59). Results for five questions significantly improved, including the likelihood of TGT impact on treatment decision, incidental germline findings, and cost of testing. Improvement in video message-specific knowledge was consistent across demographic groups, including age, income, and education.
A concise, 3-4 min, broadly applicable video incorporating culturally diverse images administered prior to TGT significantly improved video message-specific knowledge across all demographic groups. This resource is publicly available at http://www.tumor-testing.com, with a goal to efficiently educate and empower patients regarding TGT while addressing guidelines within the flow of clinical practice.
肿瘤基因组检测(TGT)是大多数晚期/转移性癌症患者的标准治疗方法。尽管有既定的指南,但在进行 TGT 之前,患者教育经常被忽略。本研究的目的是评估在进行 TGT 之前使用简短的 4 分钟视频进行患者教育的效果。
基于质量改进周期,创建了一个动画视频,适用于任何癌症类型,包含文化多元化的图像,有英语和西班牙语两种版本。在一家三级学术机构中,正在接受标准护理 TGT 的患者入组,并在观看视频前(T1)和观看后立即(T2)完成调查问卷。问卷包括:(1)10 个关于基因组知识的客观问题;(2)10 个关于视频信息的具体知识问题;(3)11 个关于信任医生的问题;(4)关于 TGT 的态度。
共纳入 150 名参与者。主要目标是视频信息的具体知识显著增加(中位数增加 10 分;p<0.0001),而基因组知识/理解没有显著变化(p=0.89)或对医生/提供者的信任(p=0.59)。五个问题的答案显著改善,包括 TGT 对治疗决策、偶然发现的种系基因发现和检测成本的影响的可能性。视频信息具体知识的改善在所有年龄、收入和教育水平的人群中都是一致的。
一个简短的、3-4 分钟、广泛适用的视频,在进行 TGT 之前使用,包含文化多元化的图像,能显著提高所有人群对视频信息的具体知识。该资源在 http://www.tumor-testing.com 上公开提供,旨在通过在临床实践流程中解决指南,高效地教育和增强患者对 TGT 的了解和认知。